Altria (MO) official guidance

We now expect to deliver adjusted diluted EPS in a range of $5.61-$5.72, representing a growth rate of 3.5%-5.5% from a base of $5.42 in 2025.

In addition, we expect 2026 capital expenditures to be between $375 million and $450 million, a change from our previous expectation of $300 million to $375 million.

We anticipate Helix will continue to be profitable for the full year 2026.

We are now adding the final phases of the Initiative and continue to expect to deliver cumulative savings of at least $600 million by the end of 2029.

Target a debt-to-Consolidated EBITDA ratio of approximately 2.0x.

We expect our 2026 full-year adjusted effective tax rate to be in a range of 22.5% to 23.5%, our 2026 capital expenditures to be between $300 million and $375 million, which includes planned investments to support contract manufacturing capabilities and innovative products, and our 2026 depreciation and amortization expenses to be approximately $225 million.

A progressive dividend goal targeting mid-single digits dividend per share growth annually through 2028.

We expect our 2026 full-year adjusted effective tax rate to be in a range of 22.5% to 23.5%, our 2026 capital expenditures to be between $300 million and $375 million, which includes planned investments to support contract manufacturing capabilities and innovative products, and our 2026 depreciation and amortization expenses to be approximately $225 million.

Deliver a mid-single digits adjusted diluted EPS compounded annual growth rate (CAGR) in 2028 from a $4.871 base in 2022.

Maintain a total adjusted operating companies income (OCI) margin of at least 60% in each year through 2028.

Enter non-nicotine categories with broad commercial distribution of at least five products by 2028.

The savings estimates exclude estimated pre-tax charges of approximately $175 million, updated from our prior estimate of approximately $125 million.

We now expect to deliver adjusted diluted EPS in a range of $5.37-$5.45, representing a growth rate of 3.5%-5% from a base of $5.19 in 2024.

We expect EPS growth to moderate in the fourth quarter as we lap the lower share count associated with the 2024 accelerated share repurchase program and the benefit of the MSA Legal Fund expiration.

We continue to expect our 2025 full-year adjusted effective tax rate to be in a range of 23% to 24%, our 2025 capital expenditures to be between $175 million and $225 million and our 2025 depreciation and amortization expenses to be approximately $290 million.

We continue to expect our 2025 full-year adjusted effective tax rate to be in a range of 23% to 24%, our 2025 capital expenditures to be between $175 million and $225 million and our 2025 depreciation and amortization expenses to be approximately $290 million.

We continue to expect our 2025 full-year adjusted effective tax rate to be in a range of 23% to 24%, our 2025 capital expenditures to be between $175 million and $225 million and our 2025 depreciation and amortization expenses to be approximately $290 million.